Marc D. Kozin

Insider · Director · UFPT

Marc D. Kozin files insider transactions with the SEC as a director of Ufp Technologies (UFPT). We hold 1 disclosed purchase or sale filed since 9 June 2006, 1 of them in the last 90 days.

Files forUFPT
Disclosed buys and sells1 in all, 1 in the last 90 days
Last disclosure27 August 2026

Positions held

9 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 8 June 2006 — 25 August 2026Director · Ufp Technologies (UFPT)97 Form 4 lines · source: SEC Form 4
Filed 20 March 2024 — 21 April 2025Director · Chimerix (CMRX)4 Form 4 lines · source: SEC Form 4
Filed 23 January 2019 — 28 December 2021Director · Dicerna Pharmaceuticals (DRNA)16 Form 4 lines · source: SEC Form 4
Filed 8 September 2021 — 8 September 2021Director · Isleworth Healthcare Acquisition (ISLE)1 Form 4 line · source: SEC Form 4
Filed 25 July 2012 — 21 December 2018Director · Endocyte (ECYT)20 Form 4 lines · source: SEC Form 4
Filed 7 December 2018 — 7 December 2018Director · Millendo Therapeutics (MLND)1 Form 4 line · source: SEC Form 4
Filed 5 March 2014 — 28 September 2018Director · OvaScience (OVAS)24 Form 4 lines · source: SEC Form 4
Filed 29 June 2015 — 25 July 2018Director · Flex Pharma (FLKS)5 Form 4 lines · source: SEC Form 4
Filed 16 October 2012 — 22 January 2016Other role · Dyax (DYAX)18 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

▼ sold on the open market 3,650 shares of Ufp TechnologiesSEC Form 427 August 2026Common Stock, $.01 Par Value · traded 25 August 2026 · filed 27 August 2026
▼ sold on the open market 3,350 shares of Ufp TechnologiesSEC Form 427 August 2026Common Stock, $.01 Par Value · traded 25 August 2026 · filed 27 August 2026
was granted 802 shares of Ufp TechnologiesSEC Form 48 June 2026Common Stock, $.01 Par Value · traded 4 June 2026 · filed 8 June 2026
was granted 625 shares of Ufp TechnologiesSEC Form 46 June 2025Common Stock, $.01 Par Value · traded 4 June 2025 · filed 6 June 2025
returned to the issuer 100,000 shares of Chimerix (a derivative holding)SEC Form 421 April 2025Employee Stock Option (Right to Buy) · traded 21 April 2025 · filed 21 April 2025
returned to the issuer 60,000 shares of Chimerix (a derivative holding)SEC Form 421 April 2025Employee Stock Option (Right to Buy) · traded 21 April 2025 · filed 21 April 2025
gave away 1,500 shares of Ufp TechnologiesSEC Form 43 October 2024Common Stock, $.01 Par Value · traded 6 September 2024 · filed 3 October 2024
was granted 60,000 shares of Chimerix (a derivative holding)SEC Form 421 June 2024Stock Option (Right to Buy) · traded 20 June 2024 · filed 21 June 2024
was granted 493 shares of Ufp Technologies (a derivative holding)SEC Form 47 June 2024Stock Option (Right to Buy) · traded 5 June 2024 · filed 7 June 2024
was granted 230 shares of Ufp TechnologiesSEC Form 47 June 2024Common Stock, $.01 Par Value · traded 5 June 2024 · filed 7 June 2024
was granted 100,000 shares of Chimerix (a derivative holding)SEC Form 421 March 2024Stock Option (Right to Buy) · traded 20 March 2024 · filed 21 March 2024
was granted 703 shares of Ufp Technologies (a derivative holding)SEC Form 48 June 2023Stock Option (Right to Buy) · traded 7 June 2023 · filed 8 June 2023
was granted 298 shares of Ufp TechnologiesSEC Form 48 June 2023Common Stock, $.01 Par Value · traded 7 June 2023 · filed 8 June 2023
gave away 1,000 shares of Ufp TechnologiesSEC Form 410 March 2023Common Stock, $.01 Par Value · traded 10 March 2023 · filed 10 March 2023
was granted 1,646 shares of Ufp Technologies (a derivative holding)SEC Form 410 June 2022Stock Option (Right to Buy) · traded 8 June 2022 · filed 10 June 2022
was granted 647 shares of Ufp TechnologiesSEC Form 410 June 2022Common Stock, $.01 Par Value · traded 8 June 2022 · filed 10 June 2022
returned to the issuer 3,333 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 429 December 2021Restricted Stock Units · traded 28 December 2021 · filed 29 December 2021
returned to the issuer 25,000 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 429 December 2021Director Stock Option (Right to Buy) · traded 28 December 2021 · filed 29 December 2021
returned to the issuer 25,000 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 429 December 2021Director Stock Option (Right to Buy) · traded 28 December 2021 · filed 29 December 2021
returned to the issuer 15,000 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 429 December 2021Director Stock Option (Right to Buy) · traded 28 December 2021 · filed 29 December 2021
returned to the issuer 15,000 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 429 December 2021Director Stock Option (Right to Buy) · traded 28 December 2021 · filed 29 December 2021
returned to the issuer 6,333 shares of Dicerna PharmaceuticalsSEC Form 429 December 2021Common Stock · traded 28 December 2021 · filed 29 December 2021
returned to the issuer 5,000 shares of Dicerna PharmaceuticalsSEC Form 429 December 2021Common Stock · traded 28 December 2021 · filed 29 December 2021
acquired or disposed of, other 36,000 shares of Isleworth Healthcare AcquisitionSEC Form 410 September 2021Common Stock · traded 8 September 2021 · filed 10 September 2021
▲ bought on the open market 3,000 shares of Dicerna PharmaceuticalsSEC Form 410 August 2021Common Stock · traded 10 August 2021 · filed 10 August 2021
was granted 1,786 shares of Ufp Technologies (a derivative holding)SEC Form 411 June 2021Stock Option (Right to Buy) · traded 9 June 2021 · filed 11 June 2021
was granted 610 shares of Ufp TechnologiesSEC Form 411 June 2021Common Stock, $.01 Par Value · traded 9 June 2021 · filed 11 June 2021
exercised options over 3,333 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 47 June 2021Restricted Stock Units · traded 3 June 2021 · filed 7 June 2021
was granted 3,333 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 47 June 2021Restricted Stock Units · traded 3 June 2021 · filed 7 June 2021
was granted 15,000 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 47 June 2021Director Stock Option (Right to Buy) · traded 3 June 2021 · filed 7 June 2021
exercised options over 3,333 shares of Dicerna PharmaceuticalsSEC Form 47 June 2021Common Stock · traded 3 June 2021 · filed 7 June 2021
▼ sold on the open market 500 shares of Ufp TechnologiesSEC Form 410 March 2021Common Stock, $.01 Par Value · traded 8 March 2021 · filed 10 March 2021
▼ sold on the open market 234 shares of Ufp TechnologiesSEC Form 410 March 2021Common Stock, $.01 Par Value · traded 8 March 2021 · filed 10 March 2021
▼ sold on the open market 200 shares of Ufp TechnologiesSEC Form 410 March 2021Common Stock, $.01 Par Value · traded 8 March 2021 · filed 10 March 2021
▼ sold on the open market 8,466 shares of Ufp TechnologiesSEC Form 410 March 2021Common Stock, $.01 Par Value · traded 8 March 2021 · filed 10 March 2021
▼ sold on the open market 600 shares of Ufp TechnologiesSEC Form 410 March 2021Common Stock, $.01 Par Value · traded 8 March 2021 · filed 10 March 2021
gave away 4,000 shares of Ufp TechnologiesSEC Form 410 March 2021Common Stock, $.01 Par Value · traded 8 March 2021 · filed 10 March 2021
was granted 3,333 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 416 June 2020Restricted Stock Units · traded 15 June 2020 · filed 16 June 2020
was granted 15,000 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 416 June 2020Director Stock Option (Right to Buy) · traded 15 June 2020 · filed 16 June 2020
was granted 2,482 shares of Ufp Technologies (a derivative holding)SEC Form 412 June 2020Stock Option (Right to Buy) · traded 10 June 2020 · filed 12 June 2020
was granted 796 shares of Ufp TechnologiesSEC Form 412 June 2020Common Stock, $.01 Par Value · traded 10 June 2020 · filed 12 June 2020
▼ sold on the open market 200 shares of Ufp TechnologiesSEC Form 411 March 2020Common Stock, $.01 Par Value · traded 10 March 2020 · filed 11 March 2020
▼ sold on the open market 2,600 shares of Ufp TechnologiesSEC Form 411 March 2020Common Stock, $.01 Par Value · traded 10 March 2020 · filed 11 March 2020
▼ sold on the open market 1,133 shares of Ufp TechnologiesSEC Form 411 March 2020Common Stock, $.01 Par Value · traded 10 March 2020 · filed 11 March 2020
▼ sold on the open market 1,000 shares of Ufp TechnologiesSEC Form 411 March 2020Common Stock, $.01 Par Value · traded 10 March 2020 · filed 11 March 2020
exercised options over 2,058 shares of Ufp TechnologiesSEC Form 410 March 2020Common Stock, $.01 Par Value · traded 6 March 2020 · filed 10 March 2020
exercised options over 1,295 shares of Ufp TechnologiesSEC Form 410 March 2020Common Stock, $.01 Par Value · traded 6 March 2020 · filed 10 March 2020
exercised options over 1,227 shares of Ufp TechnologiesSEC Form 410 March 2020Common Stock, $.01 Par Value · traded 6 March 2020 · filed 10 March 2020
exercised options over 2,088 shares of Ufp TechnologiesSEC Form 410 March 2020Common Stock, $.01 Par Value · traded 6 March 2020 · filed 10 March 2020
exercised options over 2,921 shares of Ufp TechnologiesSEC Form 410 March 2020Common Stock, $.01 Par Value · traded 6 March 2020 · filed 10 March 2020
exercised options over 2,864 shares of Ufp TechnologiesSEC Form 410 March 2020Common Stock, $.01 Par Value · traded 6 March 2020 · filed 10 March 2020
exercised options over 2,056 shares of Ufp TechnologiesSEC Form 410 March 2020Common Stock, $.01 Par Value · traded 6 March 2020 · filed 10 March 2020
exercised options over 1,724 shares of Ufp TechnologiesSEC Form 410 March 2020Common Stock, $.01 Par Value · traded 6 March 2020 · filed 10 March 2020
exercised options over 2,058 shares of Ufp Technologies (a derivative holding)SEC Form 410 March 2020Stock Option (Right to Buy) · traded 6 March 2020 · filed 10 March 2020
exercised options over 1,295 shares of Ufp Technologies (a derivative holding)SEC Form 410 March 2020Stock Option (Righto toBuy) · traded 6 March 2020 · filed 10 March 2020
exercised options over 1,227 shares of Ufp Technologies (a derivative holding)SEC Form 410 March 2020Stock Option (Right to Buy) · traded 6 March 2020 · filed 10 March 2020
exercised options over 2,088 shares of Ufp Technologies (a derivative holding)SEC Form 410 March 2020Stock Option (Right to Buy) · traded 6 March 2020 · filed 10 March 2020
exercised options over 2,921 shares of Ufp Technologies (a derivative holding)SEC Form 410 March 2020Stock Option (Right to Buy) · traded 6 March 2020 · filed 10 March 2020
exercised options over 2,864 shares of Ufp Technologies (a derivative holding)SEC Form 410 March 2020Stock Option (Right to Buy) · traded 6 March 2020 · filed 10 March 2020
exercised options over 2,056 shares of Ufp Technologies (a derivative holding)SEC Form 410 March 2020Stock Option (Right to Buy) · traded 6 March 2020 · filed 10 March 2020
exercised options over 1,724 shares of Ufp Technologies (a derivative holding)SEC Form 410 March 2020Stock Option (Right to Buy) · traded 6 March 2020 · filed 10 March 2020
▼ sold on the open market 1,535 shares of Ufp TechnologiesSEC Form 412 September 2019Common Stock, $.01 Par Value · traded 10 September 2019 · filed 12 September 2019
▼ sold on the open market 1,075 shares of Ufp TechnologiesSEC Form 412 September 2019Common Stock, $.01 Par Value · traded 10 September 2019 · filed 12 September 2019
▼ sold on the open market 3,342 shares of Ufp TechnologiesSEC Form 412 September 2019Common Stock, $.01 Par Value · traded 11 September 2019 · filed 12 September 2019
▼ sold on the open market 455 shares of Ufp TechnologiesSEC Form 412 September 2019Common Stock, $.01 Par Value · traded 11 September 2019 · filed 12 September 2019
exercised options over 2,907 shares of Ufp Technologies (a derivative holding)SEC Form 49 September 2019Stock Option (Right to Buy) · traded 5 September 2019 · filed 9 September 2019
exercised options over 3,500 shares of Ufp Technologies (a derivative holding)SEC Form 49 September 2019Stock Option (Right to buy) · traded 5 September 2019 · filed 9 September 2019
exercised options over 2,907 shares of Ufp TechnologiesSEC Form 49 September 2019Common Stock, $.01 Par Value · traded 5 September 2019 · filed 9 September 2019
exercised options over 3,500 shares of Ufp TechnologiesSEC Form 49 September 2019Common Stock, $.01 Par Value · traded 5 September 2019 · filed 9 September 2019
was granted 25,000 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 421 June 2019Director Stock Option (right to buy) · traded 20 June 2019 · filed 21 June 2019
was granted 2,756 shares of Ufp Technologies (a derivative holding)SEC Form 47 June 2019Stock Option (Right to Buy) · traded 5 June 2019 · filed 7 June 2019
was granted 907 shares of Ufp TechnologiesSEC Form 47 June 2019Common Stock, $.01 Par Value · traded 5 June 2019 · filed 7 June 2019
was granted 25,000 shares of Dicerna Pharmaceuticals (a derivative holding)SEC Form 425 January 2019Director Stock Option (Right to Buy) · traded 23 January 2019 · filed 25 January 2019
returned to the issuer 7,800 shares of EndocyteSEC Form 421 December 2018Common Stock · traded 21 December 2018 · filed 21 December 2018
returned to the issuer 3,300 shares of EndocyteSEC Form 421 December 2018Common Stock · traded 21 December 2018 · filed 21 December 2018
returned to the issuer 20,000 shares of Endocyte (a derivative holding)SEC Form 421 December 2018Stock Option (right to buy) · traded 21 December 2018 · filed 21 December 2018
returned to the issuer 14,000 shares of Endocyte (a derivative holding)SEC Form 421 December 2018Stock Option (right to buy) · traded 21 December 2018 · filed 21 December 2018
returned to the issuer 14,000 shares of Endocyte (a derivative holding)SEC Form 421 December 2018Stock Option (right to buy) · traded 21 December 2018 · filed 21 December 2018
returned to the issuer 13,500 shares of Endocyte (a derivative holding)SEC Form 421 December 2018Stock Option (right to buy) · traded 21 December 2018 · filed 21 December 2018
returned to the issuer 13,500 shares of Endocyte (a derivative holding)SEC Form 421 December 2018Stock Option (right to buy) · traded 21 December 2018 · filed 21 December 2018
returned to the issuer 19,500 shares of Endocyte (a derivative holding)SEC Form 421 December 2018Stock Option (right to buy) · traded 21 December 2018 · filed 21 December 2018
returned to the issuer 19,500 shares of Endocyte (a derivative holding)SEC Form 421 December 2018Stock Option (right to buy) · traded 21 December 2018 · filed 21 December 2018
was granted 831 shares of Millendo TherapeuticsSEC Form 411 December 2018Common Stock · traded 7 December 2018 · filed 11 December 2018
was granted 16,014 shares of OvaScienceSEC Form 42 October 2018Common Stock · traded 28 September 2018 · filed 2 October 2018
was granted 10,000 shares of Flex Pharma (a derivative holding)SEC Form 426 July 2018Stock Option (right to buy) · traded 25 July 2018 · filed 26 July 2018
was granted 12,000 shares of OvaScience (a derivative holding)SEC Form 46 July 2018Stock Option (right to buy) · traded 4 July 2018 · filed 6 July 2018
was granted 12,880 shares of OvaScienceSEC Form 43 July 2018Common Stock · traded 29 June 2018 · filed 3 July 2018
was granted 561 shares of Ufp TechnologiesSEC Form 47 June 2018Common Stock, $.01 Par Value · traded 6 June 2018 · filed 7 June 2018
was granted 1,724 shares of Ufp Technologies (a derivative holding)SEC Form 47 June 2018Stock Option (Right to Buy) · traded 6 June 2018 · filed 7 June 2018
exercised options over 2,615 shares of Ufp TechnologiesSEC Form 416 May 2018Common Stock, $.01 Par Value · traded 14 May 2018 · filed 16 May 2018
exercised options over 4,500 shares of Ufp TechnologiesSEC Form 416 May 2018Common Stock, $.01 Par Value · traded 14 May 2018 · filed 16 May 2018
exercised options over 2,615 shares of Ufp Technologies (a derivative holding)SEC Form 416 May 2018Stock Option (Right to Buy) · traded 14 May 2018 · filed 16 May 2018
exercised options over 4,500 shares of Ufp Technologies (a derivative holding)SEC Form 416 May 2018Stock Option (right to buy) · traded 14 May 2018 · filed 16 May 2018
was granted 3,300 shares of EndocyteSEC Form 44 May 2018Common Stock · traded 3 May 2018 · filed 4 May 2018
was granted 19,500 shares of Endocyte (a derivative holding)SEC Form 44 May 2018Stock Option (right to buy) · traded 3 May 2018 · filed 4 May 2018
was granted 14,411 shares of OvaScienceSEC Form 43 April 2018Common Stock · traded 30 March 2018 · filed 3 April 2018
was granted 8,348 shares of OvaScienceSEC Form 43 January 2018Common Stock · traded 29 December 2017 · filed 3 January 2018
was granted 8,230 shares of OvaScienceSEC Form 43 October 2017Common Stock · traded 29 September 2017 · filed 3 October 2017
was granted 12,000 shares of Flex Pharma (a derivative holding)SEC Form 427 July 2017Stock Option (right to buy) · traded 26 July 2017 · filed 27 July 2017
was granted 6,477 shares of OvaScienceSEC Form 45 July 2017Common Stock · traded 30 June 2017 · filed 5 July 2017
was granted 12,000 shares of OvaScience (a derivative holding)SEC Form 423 June 2017Stock Option (right to buy) · traded 21 June 2017 · filed 23 June 2017
was granted 647 shares of Ufp TechnologiesSEC Form 48 June 2017Common Stock, $.01 Par Value · traded 6 June 2017 · filed 8 June 2017
was granted 2,056 shares of Ufp Technologies (a derivative holding)SEC Form 48 June 2017Stock Option (Right to Buy) · traded 6 June 2017 · filed 8 June 2017
was granted 3,300 shares of EndocyteSEC Form 45 May 2017Common Stock · traded 4 May 2017 · filed 5 May 2017
was granted 19,500 shares of Endocyte (a derivative holding)SEC Form 45 May 2017Stock Option (right to buy) · traded 4 May 2017 · filed 5 May 2017
was granted 5,180 shares of OvaScienceSEC Form 44 April 2017Common Stock · traded 31 March 2017 · filed 4 April 2017
was granted 6,331 shares of OvaScienceSEC Form 44 January 2017Common Stock · traded 30 December 2016 · filed 4 January 2017
was granted 1,353 shares of OvaScienceSEC Form 44 October 2016Common Stock · traded 30 September 2016 · filed 4 October 2016
was granted 1,859 shares of OvaScienceSEC Form 45 July 2016Common Stock · traded 30 June 2016 · filed 5 July 2016
was granted 794 shares of Ufp TechnologiesSEC Form 413 June 2016Common Stock, $.01 Par Value · traded 9 June 2016 · filed 13 June 2016
was granted 2,864 shares of Ufp Technologies (a derivative holding)SEC Form 413 June 2016Stock Option (Right to Buy) · traded 9 June 2016 · filed 13 June 2016
was granted 10,000 shares of Flex Pharma (a derivative holding)SEC Form 49 June 2016Stock Option (right to buy) · traded 8 June 2016 · filed 9 June 2016
was granted 12,000 shares of OvaScience (a derivative holding)SEC Form 46 June 2016Stock Option (right to buy) · traded 2 June 2016 · filed 6 June 2016
exercised options over 4,500 shares of Ufp TechnologiesSEC Form 49 May 2016Common Stock, $.01 Par Value · traded 5 May 2016 · filed 9 May 2016
exercised options over 4,390 shares of Ufp TechnologiesSEC Form 49 May 2016Common Stock, $.01 Par Value · traded 5 May 2016 · filed 9 May 2016
exercised options over 4,500 shares of Ufp TechnologiesSEC Form 49 May 2016Common Stock, $.01 Par Value · traded 5 May 2016 · filed 9 May 2016
exercised options over 4,500 shares of Ufp Technologies (a derivative holding)SEC Form 49 May 2016Stock Option (Right to Buy) · traded 5 May 2016 · filed 9 May 2016
exercised options over 4,390 shares of Ufp Technologies (a derivative holding)SEC Form 49 May 2016Stock Option (Right to Buy) · traded 5 May 2016 · filed 9 May 2016
exercised options over 4,500 shares of Ufp Technologies (a derivative holding)SEC Form 49 May 2016Stock Option (Right to Buy) · traded 5 May 2016 · filed 9 May 2016
was granted 2,250 shares of EndocyteSEC Form 46 May 2016Common Stock · traded 5 May 2016 · filed 6 May 2016

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.